#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Microvillous inclusion disease Insulinoma Anti-HLA antibody test positive Pulmonary fibrosis Pleural mesothelioma malignant B-cell small lymphocytic lymphoma recurrent Soft tissue necrosis Bronchopulmonary dysplasia Plasma cell myeloma refractory Uveal melanoma Rectal cancer Hypochondroplasia Lymphatic malformation Polymyositis Shprintzen-Goldberg syndrome More trials…

    Learn about Rare Diseases

    Castleman’s disease – Treatment Small intestine leiomyosarcoma – Treatment Pelizaeus-Merzbacher disease – Life with Disease Mantle cell lymphoma refractory Adrenocortical carcinoma – Basic Information Inclusion body myositis – Basic Information Nodal marginal zone B-cell lymphoma Pulmonary fibrosis – Treatment Isodicentric chromosome 15 syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nedosiran Ro7589655 Flutemetamol (18F) Peginterferon Beta-1A Mifepristone Bi 1015550 Sparsentan Ly3556050 Benzylpenicillin Raxtozinameran Betamethasone Acetate Sphingomyelin (Egg) Valbenazine Ditosylate Ilofotase Alfa Naporafenib XENON (133XE) 11902A SONLICROMANOL HYDROCHLORIDE Elenestinib Phosphate Bepranemab More therapies…

    Learn about Your Condition

    Pneumothorax Breast cancer recurrent Chordoma Cardiac amyloidosis Anaplastic thyroid cancer Altered state of consciousness Ovarian granulosa cell tumour Alcoholic liver disease Type 2 diabetes mellitus Hyperoxaluria Vaginal haemorrhage Eructation Gastric cancer Arterial stiffness Breast angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

B-cell lymphoma

  • Study of Loncastuximab Tesirine for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma or High-Grade B-Cell Lymphoma After CAR T-Cell Therapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Loncastuximab Tesirine
    Italy

  • Study of Acalabrutinib Alone or with Rituximab for Patients with Relapsed/Refractory Marginal Zone Lymphoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell lymphoma
    Investigated Drugs:
    • Acalabrutinib
    Italy
Previous Page
1 … 3 4 5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!